Similar Papers

Paper Title
Journal
Date
Author
A multi-stakeholder platform to prospectively link longitudinal real-world clinico-genomic, imaging, and outcomes data for patients with metastatic lung cancer.
Michael W Lu ... Ariel B Bourla
Journal of Clinical Oncology | VOL. 38
Michael W Lu, et. al.Michael W Lu ... Ariel B Bourla
20 May 2020
P10.14 ctDNA and Real-World Response (rwR) in Patients With Lung Cancer From A Prospective Real-World Clinico-Genomic (PCG) Study
A Vanderwalde ... K Schulze
Journal of Thoracic Oncology | VOL. 16
A Vanderwalde, et. al.A Vanderwalde ... K Schulze
01 Oct 2021
2248. Clinical and Microbiological Outcomes Associated with Real-World Use of Ceftolozane/Tazobactam
...
Open Forum Infectious Diseases | VOL. 6
, et. al. ...
23 Oct 2019
Clinical Utility and Prognostic Value of Coronary Computed Tomography Angiography in Patients With Cancer
Muhummad Sohaib Nazir ... Alexander R Lyon
The American Journal of Cardiology | VOL. 207
Muhummad Sohaib Nazir, et. al.Muhummad Sohaib Nazir ... Alexander R Lyon
04 Oct 2023
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
A Perspective on the MARS2 Trial
Eric Lim ... Harvey Pass
Journal of Thoracic Oncology | VOL. -
Eric Lim, et. al.Eric Lim ... Harvey Pass
01 Jan 2025
Meeting Announcements
-
Journal of Thoracic Oncology | VOL. -
--
01 Jan 2025
Editorial Board
-
Journal of Thoracic Oncology | VOL. -
--
01 Jan 2025
Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage Small Cell Lung Cancer: Results From TROPiCS-03
Afshin Dowlati ... Saiama N Waqar
Journal of Thoracic Oncology | VOL. -
Afshin Dowlati, et. al.Afshin Dowlati ... Saiama N Waqar
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.